Skip to main content

AI assistant

Sign in to chat with this filing

The assistant answers questions, extracts KPIs, and summarises risk factors directly from the filing text.

Zydus Wellness Limited Director's Dealing 2022

Dec 29, 2022

62196_rns_2022-12-29_a2c1bb91-d02b-469c-bb81-cc4c0c1a8b39.pdf

Director's Dealing

Open in viewer

Opens in your device viewer

==> picture [109 x 41] intentionally omitted <==

December 29, 2022

Listing Department Code: 531335 BSE LIMITED P J Towers, Dalal Street, Fort, Mumbai-400 001 Listing Department Code: ZYDUSWELL NATIONAL STOCK EXCHANGE OF INDIA LIMITED Exchange Plaza, Bandra Kurla Complex, Bandra (E), Mumbai-400 051

Re.: Disclosure under Insider Trading Regulations

Dear Sir / Madam,

With reference to the captioned subject, please find enclosed disclosure in prescribed Form “C” under Regulation 7(2) of SEBI (Prohibition of Insider Trading) Regulations, 2015, received from Mr. Tarun Arora, Chief Executive Officer and Whole Time Director of the Company with respect to purchase of 200 Equity Shares of RS. 10/- each from the open market.

Please find the same in order.

Thanking you,

Yours faithfully,

For, ZYDUS WELLNESS LIMITED

NANDISH Digitally signed by NANDISH PRADIP JOSHI PRADIP JOSHI Date: 2022.12.29 15:45:04 +05'30' NANDISH P. JOSHI COMPANY SECRETARY

Encl.: As above

Zydus Wellness Limited

(a subsidiary of Zydus Lifesciences Limited)

Regd. Office: ‘Zydus Corporate Park’, Scheme No. 63, Survey No. 536, Khoraj (Gandhinagar), Nr. Vaishnodevi Circle, S. G. Highway, Ahmedabad – 382481, India. Phone No. : +91-79-71800000; Website : www.zyduswellness.com

CIN : L15201GJ1994PLC023490

FORM C

SEBI (Prohibition of Insider Trading) Regulations, 2015

[Regulation 7 (2) read with Regulation 6(2) – Continual disclosure]

Name of the Company: ZYDUS WELLNESS LIMITED ISIN of the Company: INE768C01010

Details of change in holding of Securities of Promoter, Member of the Promoter Group, Designated Person or Director of a listed company and immediate relatives of such persons and other such persons as mentioned in Regulation 6(2).

Name, PAN,
CIN/DIN, &
address with
contact
Category
of
Person
Securities held prior to
acquisition/disposal
Securities held prior to
acquisition/disposal
Securities acquired/Disposed Securities acquired/Disposed Securities acquired/Disposed Securities acquired/Disposed Securities held post
Purchase
Securities held post
Purchase
Date of Purchase of
shares
Date of Purchase of
shares
Date of
intimation
to
company
Mode
of Sale
Type of
securities
No. and % of
shareholding
Type of
security
No Value Transaction
Type
Type of
security
No. and % of
shareholding
From To
1 2 3 4 5 6 7 8 9 10 11 12 13 14
Name: Tarun Arora
DIN: 07185311
PAN: AADPA8011C
Address: 701,
Samprat
Residency–II,
Behind Satyagraha
Chhavani, Satellite,
Ahmedabad–380
015
Contact No.
079-48040000
CEO &
Whole
Time
Director
Equity
Shares
1,800
0.00%
Equity
Shares
200
(NSE)
Rs.
3,01,400.00
Acquired Equity
Shares
2,000
0.00%
December
28, 2022
December
28, 2022
December
29, 2022
Open
market

Details of trading in derivatives of the company by Promoter, Employee or Director of a listed company and other such persons as mentioned in Regulation 6(2).

==> picture [658 x 112] intentionally omitted <==

----- Start of picture text -----

Trading in derivatives (Specify type of contract, Futures or Options etc.) Exchange on which the trade was
Type of contract Contract specifications Buy Sell executed
Notional Number of Notional Value Number of
Value units units
(contracts (contracts
lot size) lot size)
15 16 17 18 19 20 21
N.A. N.A. N.A. N.A. N.A. N.A. National Stock Exchange of India
Limited
----- End of picture text -----

==> picture [92 x 61] intentionally omitted <==

Tarun Arora CEO & Whole Time Director

Date: December 29, 2022 Place: Mumbai